Research Topics
| Douglas FearonSummaryAffiliation: University of Cambridge Country: UK Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complexD T Fearon
Wellcome Trust Immunology Unit, Department of Medicine, School of Clinical Medicine, University of Cambridge, United Kingdom
Annu Rev Immunol 18:393-422. 2000..The integration of innate and adaptive immune recognition at this molecular site on the B cell guides the appropriate selection of antigen by adaptive immunity and emphasizes the importance of this coreceptor complex...
Arrested differentiation, the self-renewing memory lymphocyte, and vaccinationD T Fearon
Wellcome Trust Immunology Unit, School of Clinical Medicine, University of Cambridge, MRC Centre, Cambridge CB2 2SP, UK
Science 293:248-50. 2001..Understanding how to regulate the terminal differentiation of lymphocytes will improve immunotherapeutic approaches for chronic infectious diseases and cancer...
Pathways of memory CD8+ T-cell developmentOliver Bannard
Wellcome Trust Immunology Unit, Department of Medicine, University of Cambridge, Medical Research Council Centre, Cambridge, UK
Eur J Immunol 39:2083-7. 2009....
BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytesPeter M Manders
Wellcome Trust Immunology Unit, Department of Medicine, University of Cambridge, Medical Research Council Centre, Cambridge CB2 2QH, UK
Proc Natl Acad Sci U S A 102:7418-25. 2005..Therefore, BCL6b is required for the enhanced magnitude of the secondary response of memory CD8(+) T cells...
The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cellsDouglas T Fearon
Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK
Immunol Rev 211:104-18. 2006..The challenge is now to identify this unknown pathway of clonal expansion...
The expansion and maintenance of antigen-selected CD8(+) T cell clonesDouglas T Fearon
Wellcome Trust Immunology Unit, University of Cambridge, Medical Research Council Centre, Cambridge CB2 2QH, United Kingdom
Adv Immunol 96:103-39. 2007..This developmental program ensures that despite the occurrence of cellular senescence antiviral CD8(+) T cell clones are maintained for the duration of persistent viral infections...
Biography of Douglas T. FearonRegina Nuzzo
Proc Natl Acad Sci U S A 102:7415-7. 2005
CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiationJames M Carr
Wellcome Trust Immunology Unit, Department of Medicine, University of Cambridge, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH, United Kingdom
Proc Natl Acad Sci U S A 103:19454-9. 2006..Thus, the TCR/CD27 pathway enables the CD8+ T cell to replicate by a process of self-renewal, which may contribute to the continuous generation of new effector CD8+ T cells in persistent viral infections...
Loss of T cell receptor-induced Bmi-1 in the KLRG1(+) senescent CD8(+) T lymphocyteMaike Heffner
Wellcome Trust Immunology Unit, Department of Medicine, University of Cambridge, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH, United Kingdom
Proc Natl Acad Sci U S A 104:13414-9. 2007....
Research Grants
- ANTIGEN-INDUCED B LYMPHOCYTE DEVELOPMENTDouglas Fearon; Fiscal Year: 2006..abstract_text> ..
